Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis
- PMID: 15563314
- DOI: 10.1111/j.1600-0463.2004.apm11207-0811.x
Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis
Abstract
The pace of research into the lymphatic system continues to accelerate with the availability of new molecular markers. One such marker, LYVE-1, the lymphatic receptor for the extracellular matrix mucopolysaccharide hyaluronan, has been a key component of many important studies on embryonic and tumour-induced lymphangiogenesis, and continues to be used for the detection and isolation of lymphatic endothelial cells. However, LYVE-1 is interesting in its own right. Being a member of the Link protein family whose only other major hyaluronan receptor is directly involved in leukocyte migration and tumour metastasis, LYVE-1 is already implicated in the trafficking of cells within lymphatic vessels and lymph nodes. The current challenge is to determine the precise roles played by LYVE-1 and other scavenger type receptors in the immune functions of the lymphatics as well as to use LYVE-1 and other markers to investigate the way in which tumours exploit lymphatic vessels for metastasis.
Similar articles
-
Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).J Urol. 2004 Jul;172(1):103-7. doi: 10.1097/01.ju.0000128860.00639.9c. J Urol. 2004. PMID: 15201747
-
Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis.J Pathol. 2006 May;209(1):67-77. doi: 10.1002/path.1942. J Pathol. 2006. PMID: 16482496
-
Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?Ophthalmology. 2010 Feb;117(2):334-42. doi: 10.1016/j.ophtha.2009.06.057. Epub 2009 Nov 4. Ophthalmology. 2010. PMID: 19892405
-
Lymphangiogenesis in tumors: what do we know?Microsc Res Tech. 2003 Feb 1;60(2):171-80. doi: 10.1002/jemt.10255. Microsc Res Tech. 2003. PMID: 12539171 Review.
-
Molecular and cellular mechanisms of lymphangiogenesis.Eur J Surg Oncol. 2005 Mar;31(2):117-21. doi: 10.1016/j.ejso.2004.08.015. Eur J Surg Oncol. 2005. PMID: 15698725 Review.
Cited by
-
Lymphangiogenesis is induced by mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against mycobacterial antigen.Am J Pathol. 2015 Feb;185(2):432-45. doi: 10.1016/j.ajpath.2014.09.020. Am J Pathol. 2015. PMID: 25597700 Free PMC article.
-
Of mice and men; the translational physiology of a genetic form of lymphoedema.J Physiol. 2006 Jul 15;574(Pt 2):331. doi: 10.1113/jphysiol.2006.114124. Epub 2006 May 25. J Physiol. 2006. PMID: 16728443 Free PMC article. No abstract available.
-
CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.Nanomedicine. 2014 Aug;10(6):1221-30. doi: 10.1016/j.nano.2014.02.015. Epub 2014 Mar 15. Nanomedicine. 2014. PMID: 24637218 Free PMC article.
-
The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.Cell Mol Gastroenterol Hepatol. 2016 Sep 14;2(6):733-749. doi: 10.1016/j.jcmgh.2016.09.002. eCollection 2016 Nov. Cell Mol Gastroenterol Hepatol. 2016. PMID: 28105461 Free PMC article. Review.
-
Cellular components of tumor microenvironment: understanding their role in lymphatic metastasis of tumors.Front Pharmacol. 2024 Dec 11;15:1463538. doi: 10.3389/fphar.2024.1463538. eCollection 2024. Front Pharmacol. 2024. PMID: 39726782 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
